Montréal-based healthtech startup Pathway has raised $5 million in seed funding for its AI-powered medical knowledge platform.
Pathway says 370,000 clinicians from 200 countries are registered on its platform.
Pathway says its platform compiles clinical practice guidance from millions of evidence-based sources into a database that allows healthcare professionals to search for and access medical information.
The seed round was led by Yamaha Motor Ventures, with participation from new investor Verge HealthTech Fund and existing investors Amplify Capital, BoxOne Ventures, and Formentera Capital. Pathway also said a number of its platform’s physician users participated in the round.
Pathway has also announced its decision to make its platform openly accessible with a free account and unveiled the beta version of Pathway AI, which it claims is its most advanced AI assistant and search tool to date. The new AI tool allows users to ask medical queries and receive a response drawing from Pathway’s database.
“Pathway AI combines the efficiency of large language models with our vast database
of physician-vetted data, empowering clinicians with transparent and actionable answers in seconds,” Pathway co-founder and chief medical officer Louis Mullie said in a statement. “We believe that medical knowledge should be open and accessible. Our mission with Pathway is to expand this access, ensuring every clinician has the tools they need to provide the best care possible.”
Founded in 2020 by Mullie, CEO Jonathan Hershon Saint-Jean, and chief technology officer Christophe Marois, Pathway claims 370,000 clinicians from 200 countries are registered on its platform, which it says offers over 70,000 recommendations on 30,000 clinical topics.
According to its editorial policy, everything in Pathway’s database must be available in an English-language, peer-reviewed journal online that is produced by a recognized medical specialty association, professional medical society, or a recognized group of medical experts. The addition is then reviewed and assigned an “evidence grade.”
The funding comes just over two years after Pathway’s $1.6-million pre-seed round, which the company used to create its platform.
Now that the platform is in use, Pathway says it will use the seed funding to improve the platform’s user experience, introduce new features, and broaden its reach to support clinicians globally.
Image courtesy Pathway via Facebook.